Autoimmunity: Limited progress for the patient, despite decades of research

Scandinavian Journal of Immunology

Volumn 70, Issue 5, 2009, Pages 411-414

  Delaleu, Nicolas ^a   Peck, Ammon B ^b,c  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ADAPTIVE IMMUNITY; ADDISON DISEASE; ALLERGIC ENCEPHALOMYELITIS; ARTHRITIS; AUTOIMMUNITY; DIABETES MELLITUS; EDITORIAL; HUMAN; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MEDICAL RESEARCH; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RHEUMATIC DISEASE;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; BIOMEDICAL RESEARCH; HUMANS;

EID: 70350498930     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2009.02318.x     Document Type: Editorial

References (53)

1. Burnet FM. The Nobel Lectures in Immunology. The Nobel Prize for Physiology or Medicine, 1960. Immunologic recognition of self. Scand J Immunol 1991 33 : 3 13.
2. Cohen IR. Tending Adam's Garden; Evolving the Cognitive Immune Self. London : Elsevier Academic Press, 2004, ISBN: 0-12-178356-1.
3. Ulvestad E. Defending Live: The Nature of Host-Parasite Relations. Dordrecht : Springer, 2007, ISBN: 978-1-4020-5675-8.
4. Belkaid Y, Tarbell K. Regulatory T cells in the control of host-microorganism interactions (*). Annu Rev Immunol 2009 27 : 551 589.
5. Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993 14 : 426 430.
6. Vincent A. Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol 2002 2 : 797 804.
7. Delaleu N, Jonsson R, Koller MM. Sjögren's syndrome. Eur J Oral Sci 2005 113 : 101 113.
8. Janeway CA Jr., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002 20 : 197 216.
9. Vance RE. Cutting edge: cutting edge commentary: a Copernican revolution? Doubts about the danger theory. J Immunol 2000 165 : 1725 1728.
10. Matzinger P. The danger model: a renewed sense of self. Science 2002 296 : 301 305.
11. Amu S, Tarkowski A, Dorner T, Bokarewa M, Brisslert M. The human immunomodulatory CD25+ B cell population belongs to the memory B cell pool. Scand J Immunol 2007 66 : 77 86.
12. Dam-Tuxen R, Riise E. Antibodies against a class II HLA-peptide complex raised by active immunization of mice with antigen mimicking peptides. Scand J Immunol 2009 70 : 93 100.
13. Deepak P, Kumar S, Acharya A. Gender variation in interleukin-13 production: a possible mechanism of differential in vivo growth of a T-cell lymphoma. Scand J Immunol 2008 67 : 581 588.
14. Dimitrov JD, Roumenina LT, Doltchinkova VR, Vassilev TL. Iron ions and haeme modulate the binding properties of complement subcomponent C1q and of immunoglobulins. Scand J Immunol 2007 65 : 230 239.
15. Djerbi M, Malinowski MM, Yagita H, Zhivotovsky B, Grandien A. Participation of FLIP, RIP and Bcl-x(L) in Fas-mediated T-cell death. Scand J Immunol 2007 66 : 410 421.
16. Gunnlaugsdottir B, Skaftadottir I, Ludviksson BR. Naive human T-cells become non-responsive towards anti-TNF alpha (infliximab) treatment in vitro if co-stimulated through CD28. Scand J Immunol 2008 68 : 624 634.
17. Kanjwani DG, Marathe TP, Chiplunkar SV, Sathaye SS. Evaluation of immunomodulatory activity of methanolic extract of Piper betel. Scand J Immunol 2008 67 : 589 593.
18. Liou LB, Wu MW, Chao WJ. Macrophages and abnormal BCL-6 or c-MYC gene expression affect the resistance of peritoneal B cells to induction of hyporesponsiveness. Scand J Immunol 2009 69 : 447 456.
19. McNeill A, Spittle E, Backstrom BT. Partial depletion of CD69 low-expressing natural regulatory T cells with the anti-CD25 monoclonal antibody PC61. Scand J Immunol 2007 65 : 63 9.
20. Narvi E, Nera KP, Terho P, Mustonen L, Granberg J, Lassila O. Aiolos controls gene conversion and cell death in DT40 B cells. Scand J Immunol 2007 65 : 503 513.
21. Potlukova E, Kralikova P. Complement component c1q and anti-c1q antibodies in theory and in clinical practice. Scand J Immunol 2008 67 : 423 430.
22. Ramos-Avila A, Ventura-Gallegos JL, Zentella-Dehesa A et al. Immunomodulatory role of chloroquine and pyrimethamine in Plasmodium yoelii 17XL infected mice. Scand J Immunol 2007 65 : 54 62.
23. Rubin B. Natural immunity has significant impact on immune responses against cancer. Scand J Immunol 2009 69 : 275 290.
24. Sjoberg K, Roth EB, Gustavsson L et al. Autoimmune markers in lymphoid malignancies. Scand J Immunol 2008 67 : 509 515.
25. Sun JB, Czerkinsky C, Holmgren J. Sublingual 'oral tolerance' induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells. Scand J Immunol 2007 66 : 278 286.
26. Wang Q, Sun B, Wang D et al. Murine bone marrow mesenchymal stem cells cause mature dendritic cells to promote T-cell tolerance. Scand J Immunol 2008 68 : 607 615.
27. Wallden J, Ilonen J, Roivainen M, Ludvigsson J, Vaarala O. Effect of HLA genotype or CTLA-4 polymorphism on cytokine response in healthy children. Scand J Immunol 2008 68 : 345 350.
28. Ahangari G, Naderimanesh H, Hossein-Nezhad A, Zouali M. A novel tissue engineering-based assay for immunological infertility. Scand J Immunol 2008 68 : 463 468.
29. Canzler U, Bartsch H, Ulitzsch S et al. Detection of autoantibodies to tumour-associated antigens in sera of patients with systemic autoimmunity using a novel protein microblot array. Scand J Immunol 2009 69 : 563 569.
30. Bielecki B, Mazurek A, Wolinski P, Glabinski A. Expression of chemokine receptors CCR7 and CCR8 in the CNS during ChREAE. Scand J Immunol 2007 66 : 383 392.
31. Emmer A, Gerlach K, Staege MS, Kornhuber ME. Cerebral gene expression of superantigen encephalitis in the lewis rat induced by staphylococcal enterotoxin a. Scand J Immunol 2008 67 : 464 472.
32. Lavasani S, Dzhambazov B, Andersson M. Monoclonal antibody against T-cell receptor alphabeta induces self-tolerance in chronic experimental autoimmune encephalomyelitis. Scand J Immunol 2007 65 : 39 47.
33. Piao WH, Jee YH, Liu RL et al. IL-21 modulates CD4+ CD25+ regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis. Scand J Immunol 2008 67 : 37 46.
34. Thuy-Tien H, Haugen M, Aarseth J, Storstein A, Vedeler CA. Proteasome antibodies in patients with cancer or multiple sclerosis. Scand J Immunol 2008 67 : 400 403.
35. Wang GY, Sun B, Kong QF et al. IL-17 eliminates the therapeutic effects of myelin basic protein-induced nasal tolerance in experimental autoimmune encephalomyelitis by activating IL-6. Scand J Immunol 2008 68 : 589 597.
36. Bohmova K, Hladikova Z, Cerny M et al. Cord blood cytokine profile detection in neonates with T1D parents - monitoring of cellular auto-reactivity using protein microarray. Scand J Immunol 2007 66 : 563 571.
37. Hassler S, Peltonen L, Sandler S, Winqvist O. Aire deficiency causes increased susceptibility to streptozotocin-induced murine type 1 diabetes. Scand J Immunol 2008 67 : 569 580.
38. Stechova K, Spalova I, Durilova M et al. Influence of maternal hyperglycaemia on cord blood mononuclear cells in response to diabetes-associated autoantigens. Scand J Immunol 2009 70 : 149 158.
39. Wolff AS, Myhr KM, Vedeler CA, Husebye ES. Fc-gamma receptor polymorphisms are not associated with autoimmune Addison's disease. Scand J Immunol 2007 65 : 555 558.
40. Adlesic M, Verdrengh M, Bokarewa M, Dahlberg L, Foster SJ, Tarkowski A. Histamine in rheumatoid arthritis. Scand J Immunol 2007 65 : 530 537.
41. Amu S, Stromberg K, Bokarewa M, Tarkowski A, Brisslert M. CD25-expressing B-lymphocytes in rheumatic diseases. Scand J Immunol 2007 65 : 182 191.
42. Wang Y, Jia L, Wu CY. Triptolide inhibits the differentiation of Th17 cells and suppresses collagen-induced arthritis. Scand J Immunol 2008 68 : 383 390.
43. Weiss RJ, Erlandsson Harris H, Palmblad K. Highly arthritis-susceptible DA rats express IL-1beta in articular cartilage. Scand J Immunol 2009 69 : 188 193.
44. Bam M, Bagchi T. Absence of tyrosinase-related protein-2/dopachrome tautomerase transcripts in PBMCs from vitiligo patients. Scand J Immunol 2009 69 : 366 373.
45. Ben-David H, Venkata Aruna B, Sela M, Mozes E. A dual altered peptide ligand inhibits myasthenia gravis associated responses by inducing phosphorylated extracellular-regulated kinase 1,2 that upregulates CD4+ CD25+ Foxp3+ cells. Scand J Immunol 2007 65 : 567 576.
46. Bodil Roth E, Theander E, Londos E et al. Pathogenesis of autoimmune diseases: antibodies against transglutaminase, peptidylarginine deiminase and protein-bound citrulline in primary Sjögren's syndrome, multiple sclerosis and Alzheimer's disease. Scand J Immunol 2008 67 : 626 631.
47. Nakatani K, Qu WM, Zhang MC et al. A genetic locus controlling aging-sensitive regression of B lymphopoiesis in an autoimmune-prone MRL/lpr strain of mice. Scand J Immunol 2007 66 : 654 661.
48. Safrany E, Pazar B, Csongei V et al. Variants of the IL23R gene are associated with ankylosing spondylitis but not with Sjögren syndrome in Hungarian population samples. Scand J Immunol 2009 70 : 68 74.
49. Sun B, Li HL, Wang JH et al. Passive transfer of experimental autoimmune neuritis by IL-12 and IL-18 synergistically potentiated lymphoid cells is regulated by NKR-P1+ cells. Scand J Immunol 2007 65 : 412 420.
50. Werwitzke S, Tiede A, Jacobs R et al. CD8 alpha+beta(low) effector T cells in systemic lupus erythematosus. Scand J Immunol 2008 67 : 501 508.
51. von Herrath M, Nepom GT. Animal models of human type 1 diabetes. Nat Immunol 2009 10 : 129 132.
52. Singh VK, Nagaraju K. Experimental autoimmune uveitis: molecular mimicry and oral tolerance. Immunol Res 1996 15 : 323 346.
53. Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 2004 4 : 583 594.